Balance Sheet Data

Neurones S.A. (NRO.PA)

39.45 €

-0.20 (-0.50%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 174.95218.61266.60265.17272.06310.60335.61362.64391.84423.39
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories 0.280.380.630.890.350.660.710.770.830.90
Inventories (%)
Accounts Payable 31.2531.0432.6637.7342.9345.5049.1753.1357.4162.03
Accounts Payable (%)
Capital Expenditure -6.95-7.89-7.19-6.58-10.60-10.16-10.98-11.86-12.81-13.85
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.